Bleeding diathesis: Difference between revisions
Nazia Fuad (talk | contribs) |
|||
Line 5: | Line 5: | ||
== Overview == | == Overview == | ||
Bleeding diathesis is unusual susceptibility to bleed due to [[Coagulopathy|coagulopathies]]. These diseases can occur due to a disorder of [[homeostasis]], localized process ([[tissue]] injury), or [[Medication|medications]]. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from | Bleeding diathesis is unusual susceptibility to bleed due to hypo-[[Coagulopathy|coagulopathies]]. These diseases can occur due to a disorder of [[homeostasis]], localized process ([[tissue]] injury), or [[Medication|medications]]. Bleeding diathesis can be resulted from [[vessel wall]] injury, [[platelet]] disorders, and [[coagulation factor]] disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. [[Platelet]] disorders mostly have skin manifestations such as [[Petechia|petechiae]], and [[ecchymoses]]. In order to find the cause of hypo-[[coagulopathy]], there are established laboratory tests that might be used. These laboratory tests such as [[peripheral blood smear]], [[platelet]] count and [[platelet]] function analysis, [[coagulation factor]] deficiencies and inhibitors, [[fibrinolysis]] tests (eg. [[D-dimer]] level), [[bleeding time]], [[prothrombin time]], [[Partial thromboplastin time|activated partial thromboplastin time]], [[thrombin time]] and reptilase time. | ||
== Classification == | == Classification == |
Revision as of 15:33, 30 August 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2], Nazia Fuad M.D.
Overview
Bleeding diathesis is unusual susceptibility to bleed due to hypo-coagulopathies. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of hypo-coagulopathy, there are established laboratory tests that might be used. These laboratory tests such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time, prothrombin time, activated partial thromboplastin time, thrombin time and reptilase time.
Classification
Differential Diagnosis
Category | Sub-category | Diseases | History | Clinical manifestation | Laboratory testing | Comments | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematomas | Hemarthrosis | platelet count | Bleeding time (BT) | Prothrombin time (PT) | Platelet count activated partial thromboplastin time (aPTT) | Thrombin time (TT) | |||||
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia | + | + | ↓ | N | N | |||||||
Medications-Induced Thrombocytopenia | History of medications | + | + | ↓ | N | N | ||||||||
Heparin-Induced Thrombocytopenia |
|
+ | + | ↓ | ||||||||||
Immune Thrombocytopenic Purpura (ITP) | + | + | ↓ | ↑ | N | N | ||||||||
Inherited Thrombocytopenia | ↓ | ↑ | N | N | ||||||||||
Thrombotic Thrombocytopenic Purpura (TTP) | ↑ | |||||||||||||
Hemolytic Uremic Syndrome | N | N | ||||||||||||
Thromobcytosis |
|
− | − | − | + | + | ↑ | ɴormal or slightly prolonged | ɴ | ɴ | ||||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | |||||||||||||
Acquired Disorders of Platelet Function | ||||||||||||||
Von Willebrand Disease |
|
+ | + | + | + | + | ↑ | Ν | ↑ | |||||
Vessel wall disorders | Metabolic and Inflammatory Disorders | |||||||||||||
Inherited Disorders of the Vessel Wall | ||||||||||||||
Coagulation disorders | Fibrinogen deficiency | |||||||||||||
Prothrombin deficiency | ||||||||||||||
Factor V deficiency | ||||||||||||||
Factor VII deficiency | ||||||||||||||
Factor X deficiency | ||||||||||||||
Factor XII deficiency | ||||||||||||||
HK deficiency | ||||||||||||||
Prekallikrein deficiency | ||||||||||||||
Factor XIII deficiency | ||||||||||||||
Hemophilia | Type A deficiency |
|
_ | _ | + | + | + | Unaffected | Unaffected | Unaffected | Prolonged | N | ||
Type B deficiency |
|
_ | _ | + | + | + | Unaffected | N | N | ↑ | N | |||
Type C deficiency |
|
_ | _ | + | Rare | Rare | N | N | N | ↑ | N | |||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | _ | + | + | ↓ | ↑ | ↑ | ↑ | |||
Vitamin K Deficiency |
|
+ | + | + | + | + | N | ↑ | ↑ | Normal or mildly prolonged | ||||
Coagulation Disorders Associated with Liver Failure | ||||||||||||||
Acquired Inhibitors of Coagulation Factors |
Different types of Von willebrand diseases can be differentiate from each other based on below table:
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | Plt levels | |
---|---|---|---|---|---|---|---|---|---|
type 1 | Quantitative/ partial | ||||||||